Journal
TRANSLATIONAL RESEARCH
Volume 185, Issue -, Pages 85-93Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2017.05.002
Keywords
-
Categories
Funding
- Ministero della Salute [GR-2011-02349436]
- RRC [RRC-2015-2360454]
Ask authors/readers for more resources
Type 1 diabetes (T1D) is an irreversible degenerative disease with severe complications such as heart disease, nephropathy, neuropathy, and retinopathy. Although exogenous insulin administration is a life-saving therapy, it does not cure the disease. This review addresses the epigenetic mechanisms responsible for the development of T1D and discusses epigenetic-based strategies for prevention and treatment of the disease. We describe novel epigenetic bio-markers for the identification of susceptible individuals and the establishment of innovative therapies with epidrugs and cell therapy to regenerate the lost beta-cells. Despite the wealth of promising data regarding the potential benefits of epigenetic tools to reduce the burden of T1D, clinical trials are still very few, and this issue needs to be resolved in the near future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available